Skip to main content
. 2020 Jan 7;2020:6759808. doi: 10.1155/2020/6759808

Figure 4.

Figure 4

(a) Left ventricular remodeling (LVR) as assessed by cardiac MRI. Daily oral administration of ALA initiated 1 day post-AMI significantly reduced left ventricular end-systolic volume (LVESV) relative to controls, both at 28 and 56 days post-AMI (P < 0.05 vs. control at either time point). (b) Left ventricular function as assessed by cardiac MRI. Daily oral administration of ALA initiated 1 d post-AMI significantly preserved left ventricular ejection fraction (LVEF) relative to controls, both at day 28 and 56 days post-AMI (∗: P < 0.05 vs. H2O-treated group at either time point).